July 13, 2022 by Chain Drug Review
B. Douglas Hoey is chief executive officer of the National Community Pharmacists Association., NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Pharmacists who believe they are acting in good faith in accordance with their state’s laws on abortion shouldn’t be left without a clear pathway forward in response to new guidance by the federal Department of Health and Human Services Office of Civil Rights, said the National Community Pharmacists Association. “States have provided very
June 29, 2022 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association is pleased to announce these upcoming items for pharmacists and pharmacy team members: July 27 – Put Me In, Coach! Building Your Pharmacy Team webinar. Support staff can play key roles in pharmacy workflow, provide enhanced services, and improve the bottom line. During this webinar a panel of
June 23, 2022 by Chain Drug Review
Federal Trade Commission Chair Lina Khan, Michele Belcher, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Michele Belcher, president of the National Community Pharmacists Association and owner of Grants Pass Pharmacy in Grants Pass, Ore., explained to Federal Trade Commission Chair Lina Khan, two key lawmakers, and others how pharmacy benefit managers are gaming the system, harming patients, and driving local pharmacies out of business. “We are so
June 22, 2022 by Chain Drug Review
B. Douglas Hoey, NCPA
Pharmacy
ALEXANDRIA, Va. – The Senate Committee on Commerce, Science, and Transportation today voted to advance the Pharmacy Benefit Manager Transparency Act (S. 4293), which was introduced by Sens. Maria Cantwell (D-Wash.) and Chuck Grassley (R-Iowa) and endorsed by the National Community Pharmacists Association. The committee advanced the bill in a bipartisan vote of 19-9. After the vote, NCPA
June 13, 2022 by Chain Drug Review
ational Community Pharmacists Association’s 2022 Annual Convention, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Registration opens Tuesday, June 14 for the National Community Pharmacists Association’s 2022 Annual Convention, set for Oct. 1-4, in Kansas City, Mo. This will be NCPA’s second in-person convention since the start of the COVID-19 pandemic. NCPA president Michele Belcher says it will be a great opportunity to get together with colleagues
June 7, 2022 by Chain Drug Review
B. Douglas Hoey is chief executive officer of the National Community Pharmacists Association., NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association is hailing a move by the Federal Trade Commission to proceed with a 6(b) study of pharmacy benefit managers and anticompetitive business practices. After the commission in February split 2-2 on a proposal to launch a formal study into PBMs, FTC Chair Lina Khan pledged to call for another
June 1, 2022 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association announces these upcoming events for pharmacists and pharmacy team members: June 1 – Realizing the Opportunity to Bill for Diabetes Education: Online Q&A forum. Community pharmacy owner Travis Wolff, PharmD, is back to answer questions around pharmacy-led diabetes education services. Wolff has successfully launched a DSME program in
May 25, 2022 by Chain Drug Review
Federal Trade Commission, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Three massive corporations integrating the largest insurance companies, big-box pharmacies, and pharmacy benefit middlemen in the world are strangling competition and bleeding patients, said the National Community Pharmacists Association in comments submitted to the Federal Trade Commission. NCPA outlined the “staggering scope” of practices that distort the pharmacy market against independent competitors,
May 24, 2022 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association is strongly supporting the Pharmacy Benefit Manager Transparency Act, new legislation introduced today by Sens. Maria Cantwell (D, Wash.) and Chuck Grassley (R, Iowa). The bill would give the Federal Trade Commission and state attorneys general the ability to penalize and/or initiate legal action against pharmacy benefit managers
May 18, 2022 by Chain Drug Review
NCPA, Rutledge v. PCMA Supreme Court case
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – In testimony today to the Texas House of Representatives’ Insurance Committee, National Community Pharmacists Association General Counsel Matthew Seiler said that given recent court rulings including the Rutledge v. PCMA Supreme Court case, Texas can take comfort in extending its existing commonsense laws regulating pharmacy benefit managers so they also apply to PBMs serving self-funded
May 11, 2022 by Chain Drug Review
B. Douglas Hoey, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association issued the following statement from CEO B. Douglas Hoey after Alvaro Bedoya was confirmed by the U.S. Senate to serve on the Federal Trade Commission: “NCPA supported Alvaro Bedoya’s nomination because we believe that he shares the commitment to investigating pharmacy benefit managers and empowering consumer choice
May 10, 2022 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – With virtually every state having enacted some type of pharmacy benefit manager regulation, ensuring that these policies are actually being enforced is becoming increasingly important. The National Community Pharmacists Association is launching a new resource to help pharmacists and patients report possible violations to state insurance regulators and push them to enforce
May 2, 2022 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association says the Biden administration’s decision to advance reforms to controversial, backdoor price concessions that increase patient drug costs is welcome progress, but delaying implementation until 2024 is a missed opportunity for patients and pharmacies. Fixing pharmacy DIR fees has been NCPA’s top advocacy priority for years. NCPA
April 28, 2022 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association announces the following pcoming events for pharmacists and pharmacy team members: • May 17 – Billing for Diabetes Education Just Got Easier, CE webinar. The 2022 National Standards for Diabetes Self-Management Education have been updated to reflect current-day practice, making it easier than ever to care for patients